Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Anel

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Pediatric Research|September 4, 2015
Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutationRaquel Ruiz-García, Sergio Mora, Gema Lozano-Sánchez, et al.
Biomedicines|June 24, 2022
Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral TreatmentPatricia Guerrero-Ochoa, Raquel Ibáñez-Pérez, Germán Berbegal-Pinilla, et al.
Oncoimmunology|November 7, 2022
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosisAlfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, et al.
Cancers|July 24, 2019
Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer CellsJoaquín Marco-Brualla, Sameer Al-Wasaby, Ruth Soler, et al.
Oncoimmunology|October 25, 2019
Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxinRaquel Ibáñez-Pérez, Patricia Guerrero-Ochoa, Sameer Al-Wasaby, et al.
Haematologica|May 7, 2011
Phenotypic and functional evaluation of CD3+CD4-CD8- T cells in human CD8 immunodeficiencyIván Bernardo, Esther Mancebo, Ignacio Aguiló, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2010
Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathwaySeyma Charni, Geoffroy de Bettignies, Moeez G Rathore, et al.
Frontiers in Immunology|November 12, 2016
Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia CellsDiego Sánchez-Martínez, Pilar M Lanuza, Natalia Gómez, et al.
Scientific Reports|January 26, 2022
Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)Nerea Allende-Vega, Joaquin Marco Brualla, Paolo Falvo, et al.
Oncoimmunology|January 18, 2021
Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patientsChantal Reina-Ortiz, Michael Constantinides, Alexis Fayd-Herbe-de-Maudave, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Pediatric Research|September 4, 2015
Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutationRaquel Ruiz-García, Sergio Mora, Gema Lozano-Sánchez, et al.
Biomedicines|June 24, 2022
Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral TreatmentPatricia Guerrero-Ochoa, Raquel Ibáñez-Pérez, Germán Berbegal-Pinilla, et al.
Oncoimmunology|November 7, 2022
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosisAlfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, et al.
Cancers|July 24, 2019
Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer CellsJoaquín Marco-Brualla, Sameer Al-Wasaby, Ruth Soler, et al.
Oncoimmunology|October 25, 2019
Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxinRaquel Ibáñez-Pérez, Patricia Guerrero-Ochoa, Sameer Al-Wasaby, et al.
Haematologica|May 7, 2011
Phenotypic and functional evaluation of CD3+CD4-CD8- T cells in human CD8 immunodeficiencyIván Bernardo, Esther Mancebo, Ignacio Aguiló, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2010
Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathwaySeyma Charni, Geoffroy de Bettignies, Moeez G Rathore, et al.
Frontiers in Immunology|November 12, 2016
Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia CellsDiego Sánchez-Martínez, Pilar M Lanuza, Natalia Gómez, et al.
Scientific Reports|January 26, 2022
Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)Nerea Allende-Vega, Joaquin Marco Brualla, Paolo Falvo, et al.
Oncoimmunology|January 18, 2021
Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patientsChantal Reina-Ortiz, Michael Constantinides, Alexis Fayd-Herbe-de-Maudave, et al.
Pageof 10